LC-MS/MS columns for Helse Bergen HF

Sykehusinnkjøp HF

The objective of the procurement is to procure columns for use in LC-MS/MS analysis of urine, blood and spit. Tenders are wanted for the following columns: 1. Pursuit 3 C18 100 x 4.6mm 3 μm 2. Zorbax Eclipse XDB-C18 4.6x50mm 1.8μm 400 bar 3. Zorbax Eclipse XDB-C18, 3.0x50mm, 1.8μm 600bar 4. Zorbax Eclipse Plus C18 RHD, 2.1 x 50 mm, 1.8 μm 5. CarpenterLab Poroshell 120 Chiral-V, 2.7 μm, 2.1 x 150 mm The columns shall be used for routine determination of protoporfyrin IX in erytrocytes (1), porphytes in faeces, plasma and urine (2), MMA (3), steroid hormones in serum (4) and kiral separation of amphetamines in spit and urine (5). Other areas of use and sample matrix can be used. The columns are sometimes also used for research analyses, i.e. determination of substances in serum, plasma, urine and/or spinal fluid. A framework agreement shall be signed for the procurement of columns. See Annex 1 - Price Form for the estimated volume. The stated consumption/extent is an estimate for information to the tenderer and is not binding for the future contract volume. If different pack sizes can be offered (e.g. packs of three), the Contracting Authority would like to receive tenders for the pack size that will give the lowest unit price. See Annex 2 - Requirement Specification and Annex 1 - Price Form for further details.

Frist

Deadline 2026-07-03

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2026-06-16 Kunngjøring av konkurranse
Kunngjøring av konkurranse (2026-06-16)
Gjenstand
Anskaffelsens omfang
Tittel: LC-MS/MS columns for Helse Bergen HF
Kort beskrivelse:
The objective of the procurement is to procure columns for use in LC-MS/MS analysis of urine, blood and spit. Tenders are wanted for the following columns: 1. Pursuit 3 C18 100 x 4.6mm 3 μm 2. Zorbax Eclipse XDB-C18 4.6x50mm 1.8μm 400 bar 3. Zorbax Eclipse XDB-C18, 3.0x50mm, 1.8μm 600bar 4. Zorbax Eclipse Plus C18 RHD, 2.1 x 50 mm, 1.8 μm 5. CarpenterLab Poroshell 120 Chiral-V, 2.7 μm, 2.1 x 150 mm The columns shall be used for routine determination of protoporfyrin IX in erytrocytes (1), porphytes in faeces, plasma and urine (2), MMA (3), steroid hormones in serum (4) and kiral separation of amphetamines in spit and urine (5). Other areas of use and sample matrix can be used. The columns are sometimes also used for research analyses, i.e. determination of substances in serum, plasma, urine and/or spinal fluid. A framework agreement shall be signed for the procurement of columns. See Annex 1 - Price Form for the estimated volume. The stated consumption/extent is an estimate for information to the tenderer and is not binding for the future contract volume. If different pack sizes can be offered (e.g. packs of three), the Contracting Authority would like to receive tenders for the pack size that will give the lowest unit price. See Annex 2 - Requirement Specification and Annex 1 - Price Form for further details.
Vis mer
Kontrakttype: Varer
Produkter/tjenester: Laboratorie-, optisk- og presisjonsutstyr (bortsett fra briller) 📦
Beskrivelse
Beskrivelse av anskaffelsen:
The objective of the procurement is to procure columns for use in LC-MS/MS analysis of urine, blood and spit.  Tender offers are wanted on the following columns: 1. Pursuit 3 C18 100 x 4.6mm 3 μm 2. Zorbax Eclipse XDB-C18 4.6x50mm 1.8μm 400 bar 3. Zorbax Eclipse XDB-C18, 3.0x50mm, 1.8μm 600bar 4. Zorbax Eclipse Plus C18 RHD, 2.1 x 50 mm, 1.8 μm 5. aralallab Poroshell 120 Chiral-V, 2.7 μm, 2.1 x 150 mm Columns shall be used for routine determination of protoporfyrin IX in erytrocytes (1), porphytes in faeces, plasma and urine (2), MMA (3), steroid hormones in serum (4) and kiral separation of amphetamines in spit and urine (5). Other areas of use and sample matrix can be used. Columns will sometimes also be used for research analyses, i.e. determination of substances in serum, plasma, urine and/or spinal fluid. See Annex 1 - Price Form for the estimated volume. The stated consumption/extent is an estimate for information to the tenderer and is not binding for the future contract volume.  If different pack sizes can be offered (e.g. packs of three), the Contracting Authority would like to receive tenders for the pack size that will give the lowest unit price.    See Annex 2 - Requirement Specification and Annex 1 - Price Form for further details.
Vis mer
Tilleggsprodukter/-tjenester: Kromatografer 📦
Land: Norge 🇳🇴
Utførelsessted: Rogaland 🏙️
Varighet: 48 måneder
Tittel
Identifikasjonsnummer for delkontrakt: LOT-0001

Prosedyre
Prosedyretype
Åpen anbudskonkurranse
Rettslig grunnlag: Direktiv 2014/24/EU
Administrativ informasjon
Frist for mottak av tilbud eller forespørsler om deltakelse: 2026-07-03 10:00:00 📅
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: norsk 🗣️
Minste tidsramme som tilbyderen må opprettholde tilbudet i: 6 måneder
Informasjon om en rammeavtale eller en dynamisk innkjøpsordning
Rammeavtale med flere leverandører
Maksimalt antall deltakere: 100
Anbudsvilkår
Elektronisk fakturering: Påkrevd
Elektronisk bestilling vil bli brukt
Elektronisk betaling vil bli brukt
Kontrakten har gjennomføringsvilkår

Oppdragsgiver
Navn og adresser
Navn: Sykehusinnkjøp hf
Nasjonalt registreringsnummer: 916879067
Postnummer: 9811
Poststed: Vadsø
Region: Finnmark/Finnmárku/Finmarkku 🏙️
Land: Norge 🇳🇴
E-post: post@sykehusinnkjop.no 📧
Telefon: 78950700 📞
Type oppdragsgiver
Offentligrettslig organ
Hovedaktivitet
Helse
Kommunikasjon
URL for dokumenter: https://sykehusinnkjop.ivalua.app/page.aspx/nb/rfp/request_browse_public 🌏
Deltakelses-URL: https://sykehusinnkjop.ivalua.app/page.aspx/nb/rfp/request_browse_public 🌏
Elektronisk innsending: Påkrevd

Utfyllende informasjon
Organ ansvarlig for meklingsprosedyrer
Navn: Indre og Østre Finnmark Tingrett
Nasjonalt registreringsnummer: 926722840
Postnummer: 9800
Poststed: Vadsø
Region: Finnmark/Finnmárku/Finmarkku 🏙️
Land: Norge 🇳🇴
E-post: indre.og.ostre.finnmark.tingrett@domstol.no 📧
Telefon: 78011700 📞
Klageinstans
Samme som: Navn og adresser
Informasjon om elektroniske arbeidsflyter
Elektronisk fakturering vil bli akseptert
Kilde: OJS 2026/S 115-415057 (2026-06-16)